Latest Articles
‘Young and the Restless’ Star Opens Up About Finding Hope After ‘Decades of Pain’ - Closer Weekly
‘Young and the Restless’ Star Opens Up About Finding Hope After ‘Decades of Pain’ Closer Weekly
Published: June 17, 2026, 1:59 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - First India
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case First India
Published: June 17, 2026, 1:57 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth In Advanced Endometriosis Case - outlookbusiness.com
Bliss IVF Highlights Fertility Success Through Twin Birth In Advanced Endometriosis Case outlookbusiness.com
Published: June 17, 2026, 1:44 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - NewsX
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case NewsX
Published: June 17, 2026, 1:06 p.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - beQuoted
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat beQuoted
Published: June 17, 2026, 9 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - The Manila Times
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat The Manila Times
Published: June 17, 2026, 8:29 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Yahoo Finance Singapore
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Yahoo Finance Singapore
Published: June 17, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Dagens industri
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Dagens industri
Published: June 17, 2026, 7:01 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Cision News
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Cision News
Published: June 17, 2026, 7 a.m.
‘Bawled my eyes out’: Abortion activist on the cost of speaking out - InDaily South Australia
‘Bawled my eyes out’: Abortion activist on the cost of speaking out InDaily South Australia
Published: June 17, 2026, 3 a.m.
Link copied to clipboard!